| |
| |
|
| Insider
Information: |
Stuart Nancy |
| Relationship: |
Chief Operating Officer |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -45.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Concert Pharmaceuticals, Inc. |
CNCE |
Chief Operating Officer |
2023-03-06 |
0 |
2014-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(73,233) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(167,963) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2023-02-15 |
4 |
AS |
$8.33 |
$50,380 |
D/D |
(6,048) |
262,596 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2023-01-30 |
4 |
AS |
$8.35 |
$110,220 |
D/D |
(13,200) |
268,644 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2023-01-06 |
4 |
AS |
$7.25 |
$20,974 |
D/D |
(2,893) |
281,844 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2022-02-14 |
4 |
AS |
$3.08 |
$18,631 |
D/D |
(6,049) |
284,737 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
120,400 |
290,786 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2022-01-05 |
4 |
AS |
$3.19 |
$9,232 |
D/D |
(2,894) |
170,386 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2021-02-16 |
4 |
AS |
$7.32 |
$44,279 |
D/D |
(6,049) |
173,280 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
21,700 |
179,329 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2020-06-22 |
4 |
S |
$11.34 |
$116,694 |
D/D |
(10,295) |
157,629 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2020-06-22 |
4 |
OE |
$3.79 |
$80,492 |
D/D |
21,238 |
167,924 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
45,363 |
146,686 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2019-12-04 |
4 |
D |
$7.61 |
$25,996 |
D/D |
(3,416) |
101,323 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2019-12-04 |
4 |
OE |
$4.41 |
$26,001 |
D/D |
5,896 |
104,739 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2019-03-31 |
4 |
D |
$12.07 |
$106,638 |
D/D |
(8,835) |
98,843 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2019-02-06 |
4 |
OE |
$4.41 |
$126,197 |
D/D |
28,616 |
116,724 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2019-02-06 |
4 |
D |
$13.95 |
$126,192 |
D/D |
(9,046) |
107,678 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2018-11-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,850 |
88,108 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2018-07-10 |
4 |
AS |
$17.94 |
$468,697 |
D/D |
(26,127) |
89,958 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2018-07-09 |
4 |
AS |
$17.56 |
$92,890 |
D/D |
(5,291) |
116,085 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2018-03-31 |
4/A |
D |
$22.90 |
$101,172 |
D/D |
(4,418) |
121,376 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2018-03-31 |
4 |
D |
$22.90 |
$101,172 |
D/D |
(4,418) |
136,376 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2018-01-25 |
4 |
D |
$20.23 |
$223,865 |
D/D |
(11,066) |
140,794 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2018-01-25 |
4 |
OE |
$4.58 |
$223,880 |
D/D |
48,882 |
151,860 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
